# Navigantis

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/navigantis

- Industry: Medical Devices & Equipment
- Headquarters: US
- Website: www.navigantis.co
- Total disclosed funding: $9.1M
- Latest round: Series A (Apr 29, 2024)
- Investors on record: 3

## About

Based in Florida, US, and founded in 2022, Navigantis, Inc., a.k.a. Navigantis operates as a medical equipment manufacturing company that focuses on providing surgical robotics to physicians in order to treat neurovascular conditions. In April 2024, Navigantis, Inc. raised USD 9.1 million in a Series A funding led by Puma Venture Capital, with participation from Cormorant Asset Management and Mirae Asset Capital. The series A funding values NAVIGANTIS Inc. at USD 32.75 million post-money.

Navigantis provides surgical robotics solutions focused on neurovascular care. Their technology supports physicians in performing precise and efficient procedures, addressing complex neurovascular conditions. The company develops advanced robotic systems designed to enhance surgical accuracy and outcomes, emphasizing innovation in the field of minimally invasive treatments for improved patient care.

The company plans to use its proceeds from April 2024 funding to support the development of the company product, the VASCO robot.

## Funding rounds

- Series A, Apr 29, 2024, $9.1M — Cormorant Asset Management, Mirae Asset Capital, Puma Venture Capital

## Investors

- Cormorant Asset Management (https://capitalatlas.ai/funds/cormorant-asset-management) — Series A
- Mirae Asset Capital (https://capitalatlas.ai/funds/mirae-asset-capital) — Series A
- Puma Venture Capital (https://capitalatlas.ai/funds/puma-venture-capital) — Series A